Supernus Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
Supernus Pharmaceuticals stock last closed at $30.29, down 1.53% from the previous day, and has increased 1.95% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.59 percentage points. Supernus Pharmaceuticals stock is currently +18.64% from its 52-week low of $25.53, and -24.8% from its 52-week high of $40.28.
At the moment, there are 55.81M SUPN shares outstanding. The market cap of SUPN is $1.69B. In the past 24 hours, 533,012 SUPN shares were traded.
How to Buy Supernus Pharmaceuticals Stock
Wondering how to invest in Supernus Pharmaceuticals stock? Here's how.
Choose where to buy Supernus Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Supernus Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Select your payment method and add your details.
Analyze Supernus Pharmaceuticals stock: The Supernus Pharmaceuticals ticker symbol is SUPN. Is Supernus Pharmaceuticals stock a good investment? Should you buy shares of SUPN? How do SUPN's underlying business fundamentals look? Do top analysts think Supernus Pharmaceuticals is a good buy? Why has SUPN's stock price moved recently? (Hint: Our stock market research website can help you decide if SUPN is a good stock to buy).
Place your SUPN purchase: Decide if you will purchase SUPN shares at the current market price or use a limit order to buy SUPN shares at a specific price.
Keep tabs on your investment in SUPN: Create a watchlist to important notifications about your new investment in Supernus Pharmaceuticals shares.
Step 1: Choose where to buy Supernus Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy SUPN stock.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy SUPN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Supernus Pharmaceuticals stock
After you have chosen the best place to buy Supernus Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually comprehend the risk and opportunity.
Supernus Pharmaceuticals shares at a glance
SUPN Price
$30.29
1w %
-4.15%
1y %
1.95%
5y %
65.88%
P/E
22.6x
P/B
1.63x
P/S
2.52x
PEG
1.04x
Revenue
$661.82M
Earnings
$73.87M
Fore. Rev. Growth
4.59%
Fore. Earn. Growth
21.78%
Market Cap
$1.69B
Next Earnings
May 6, 2025
Next Dividend
N/A
SUPN Due Diligence Checks
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
Last year, SUPN earnings were $73.87M. Over the last 5 year, SUPN's earnings have gone up by -9.11% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 5.96%.
Last year, SUPN revenue was $661.82M. In the last five year, SUPN's revenue has grown by 11% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.89%.
No, Supernus Pharmaceuticals doesn't provide an income stream by paying out dividends.
SUPN Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your SUPN purchase
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly the easiest way to buy.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you need more help buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Supernus Pharmaceuticals share?
As of Apr 21, 2025, it costs $30.29 to buy one share of Supernus Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.33 shares of SUPN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.